Appointment brings deep life sciences, clinical, & global market expertise to DiaGen as it scales its AI-driven drug discovery tools and platform abroad. VANCOUVER, BC, CANADA, March 12, 2026 / EINPresswire.com/ -- DiaGen AI Inc. (“DiaGen”), a Vancouver-based AI-driven tech-bio company building proprietary tools for small molecule and peptide discovery, today announced the appointment of Aditya Tallapragada to its Advisory Board.